Purpose: The 7th AJCC tumor node metastasis (TNM) staging system modified the classification of the lymph node metastasis widely compared to the 6th edition. To evaluate the prognostic predictability of the new TNM staging system, we analyzed the survival rate of the gastric cancer patients assessed by the 7th staging system. Materials and Methods: Among 2,083 patients who underwent resection for gastric cancer at the department of surgery, Hanyang Medical Center from July 1992 to December 2009, This study retrospectively reviewed 5-year survival rate (5YSR) of 624 patients (TanyN3M0: 464 patients, TanyNanyM1: 160 patients) focusing on the number of metastatic lymph node and distant metastasis. We evaluated the applicability of the new staging system. Results: There were no significant differences in 5YSR between stage IIIC with more than 29 metastatic lymph nodes and stage IV (P=0.053). No significant differences were observed between stage IIIB with more than 28 metastatic lymph nodes and stage IV (P=0.093). Distinct survival differences were present between patients who were categorized as TanyN3M0 with 7 to 32 metastatic lymph nodes and stage IV. But patients with more than 33 metastatic lymph nodes did not show any significant differences compared to stage IV (P=0.055). Among patients with TanyN3M0, statistical significances were seen between patients with 7 to 30 metastatic lymph nodes and those with more than 31 metastatic lymph nodes. Conclusions: In the new staging system, modifications of N classification is mandatory to improve prognostic prediction. Further study involving a greater number of cases is required to demonstrate the most appropriate cutoffs for N classification.
Introduction
According to the 6th edition of AJCC tumor node metastasis (TNM) staging system, cases in which the number of metastatic lymph node are 1~6, 7~15 and greater than 16 are determined to be N1, N2 and N3, respectively. Of these, TanyN3M0 is determined to be stage IV. (1) According to the 7th edition of AJCC TNM staging system, which was newly revised, cases in which the number of metastatic lymph node are 1~2, 3~6 and greater than 7 are determined to be N1, N2 and N3, respectively. Of these, the N3 group was sub-classified; cases in which the number of metastatic lymph node are 7~15 and greater than 16 are determined to be N3a and N3b, respectively. But TanyN3aM0 and TanyN3bM0 are classified as the same stage. (2) There are characteristics that the number of metastatic lymph node, based on which the N group is divided into N1 and N2, has a very narrow range but that, based on which it is classified into N3, has a very wide one. Besides, the N3 group is classified into stage IIb, IIIa, IIIb and IIIc although the number of metastatic lymph node is as the greatest can be. In various types of patients who were classified as the same stage, the difference in the survival rate should not reach a statistical significance (P＞0.05). In addition, if there should be a statistical significance in the differCopyrights © 2011 by The Korean Gastric Cancer Association www.jgc-online.org ence in the survival rate between the patients who were classified as the different stage (P＜0.05), the corresponding TNM staging system would be evaluated as appropriate. On the 6th edition, considering this, if the number of metastatic lymph node is greater than 16 (N3 based on the 6th edition of classification system), all the corresponding cases are classified as same stage. But there are problems that there was a significant difference in the survival rate between the group without a distant metastasis (TanyN3M0) which was classified as the stage IV and that (TanyNanyM1) which was classified as the same stage. On the 7th edition, a very simple classification system is applied based on the number of metastatic lymph node. It is necessary, however, to make a differentiation of and then to examine a prognosis of patients whose number of metastatic lymph node is very great of the groups whose number of metastatic lymph node is greater than 17. Besides, it would also be important to examine whether the new classification system might appropriately reflect a prognosis of the patients with gastric cancer based on the results of the above analysis.
Materials and Methods
Of 2,083 patients with gastric cancer who underwent gastrectomy at department of surgery at Hanyang University Medical Center during a period ranging from July of 1992 to December of 2009, in 464 patients without a distant metastasis with no respect to the degree of invasion to the gastric wall whose number of metastatic lymph node was greater than 7 (TanyN3M0) and 160 patients (stage IV) who had a distant metastasis with no respect to the degree of invasion to the gastric wall and the degree of lymph node metastasis based on the degree of lymph node metastasis and the presence of distant metastasis, the survival rate was examined and the validity of TNM staging system was analyzed. Of Stage IV patients, there were 53 cases of sub-total gastrectomy, 51 cases of total gastrectomy, 27 cases of bypass surgery and 29 cases of simple laparotomy. In regard to the sites of distant metastasis, there were 116 cases of peritoneal dissemination, 30 cases of hepatic metastasis, six cases in which there was a concurrent presence of peritoneal dissemination and hepatic metastasis, two cases of Virchow's lymph node metastasis, three cases of abdominal para-aortic lymph node metastasis and three cases in which there was a concurrent presence of Virchow's lymph node metastasis and abdominal paraaortic lymph node metastasis. Because there were cases in which there was a concurrent presence of the peritoneal dissemination, indications of the gastrectomy include cases in which the peritoneal dissemination was restricted to the proximal peritoneum around the stomach and those in which it was present very restrictively to the peritoneum below the transverse colon. In regard to cases of hepatic metastasis, excluding cases in which there were a very great number of metastatic lesions on the bilateral lobules, the systemic anti-cancer chemotherapy following the gastrectomy with no concomitant use of hepatectomy was a standard treatment regimen. In regard to the scope of lymph node dissection, the extensive lymph node dissection (D2 or higher) was performed in most of the patients (93 cases). In 11 patients whose scope of metastatic lesions was relatively more severe, the local lymph node dissection (D1) was performed. In 56 patients, the lymph node dissection was not performed. In our clinical series of patients, the median value of follow-up period was 20.5 months (the time point of final followup: June 30, 2010) and the rate of follow-up was 96.6% (603/624).
Statistical analysis was performed using SPSS ver. 13.0 (SPSS Inc., Chicago, IL, USA). Survival rate was calculated using a KaplanMeier analysis. The difference in the survival rate was analyzed using a log-rank test in order to demonstrate a statistical significance.
In regard to the statistical significance, a P-value of ＜0.05 was considered statistically significant. (Table 1) . Besides, there were 160 cases of stage IV in which there was a distant metastasis (M1). 
The distribution of the survival rate depending on the TNM stage
In a total of 624 subject patients, there was a significant difference in the survival rate depending on the TNM stage ( Table 2) . (Table 3 ).
There was no significant difference in the survival rate between
Stage IIIb (the number of metastatic lymph node ＞28) and stage IV (Table 4) .
Because there were only two Stage IIIa cases in which the number of metastatic lymph node was greater than 26, a statistical analysis could not be performed.
4.
A comparison of the survival rate depending on the number of metastatic lymph node between the TanyN3M0 group and the stage IV (TanyNanyM1) group
Of patients with TanyN3M0, in cases in which the number of metastatic lymph node was 7~32, the survival rate was significantly higher as compared with patients with stage IV. In patients whose number of metastatic lymph node was greater than 33, the difference in the survival rate reached no statistical significance as compared with stage IV patients ( Table 5 ).
A comparison of the survival rate depending on the number of metastatic lymph node in the Tany

N3M0 patient group
Of patients with TanyN3M0, there was a significant difference in the survival rate between the group where the number of metastatic lymph node was 7~30 and that where it was greater than 31 (Table 6 ). (Table 7) .
Discussion
The TNM describes the anatomical scope of tumor. As shown in "Dukes(3) classification system" proposed for colorectal cancer efforts are needed to obtain the optimal cut-off value for the number of metastatic lymph nodes. This should be followed by subclassification system. Thus, efforts should be made to differentiate these TNM stages.
